David Goldsmith

17.9k total citations · 1 hit paper
359 papers, 11.2k citations indexed

About

David Goldsmith is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, David Goldsmith has authored 359 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 170 papers in Nephrology, 82 papers in Cardiology and Cardiovascular Medicine and 69 papers in Surgery. Recurrent topics in David Goldsmith's work include Parathyroid Disorders and Treatments (84 papers), Dialysis and Renal Disease Management (78 papers) and Blood Pressure and Hypertension Studies (49 papers). David Goldsmith is often cited by papers focused on Parathyroid Disorders and Treatments (84 papers), Dialysis and Renal Disease Management (78 papers) and Blood Pressure and Hypertension Studies (49 papers). David Goldsmith collaborates with scholars based in United Kingdom, Romania and United States. David Goldsmith's co-authors include Adrian Covic, Adrian Covic, Paul Gusbeth–Tatomir, Mehmet Kanbay, Adrian Covic, Ziad A. Massy, P. Ackrill, Behdad Afzali, Adrian Covic and Richard Hull and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

David Goldsmith

351 papers receiving 10.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure

2014 310 citations Alberto Ortíz, David Goldsmith et al. The Lancet profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
David Goldsmith	5.1k	2.6k	2.0k	1.8k	1.2k	359	11.2k
Kunitoshi Iseki	8.4k 1.6×	2.9k 1.1×	1.5k 0.7×	2.2k 1.3×	1.4k 1.1×	321	13.1k
Kosaku Nitta	7.6k 1.5×	3.0k 1.1×	2.6k 1.3×	2.3k 1.3×	1.4k 1.2×	598	14.8k
Piero Ruggenenti	7.9k 1.5×	3.6k 1.4×	2.7k 1.3×	2.0k 1.1×	1.3k 1.0×	219	14.5k
Kunihiro Yamagata	5.3k 1.0×	2.6k 1.0×	2.3k 1.2×	1.9k 1.0×	933 0.8×	316	12.5k
Shin‐Wook Kang	6.1k 1.2×	1.4k 0.5×	1.7k 0.9×	1.7k 0.9×	904 0.7×	530	12.4k
Jicheng Lv	5.3k 1.0×	1.9k 0.7×	1.2k 0.6×	1.4k 0.8×	1.1k 0.9×	231	9.9k
Mehmet Kanbay	5.7k 1.1×	2.0k 0.8×	1.2k 0.6×	2.9k 1.6×	1.5k 1.3×	433	12.6k
Alfred K. Cheung	8.8k 1.7×	3.6k 1.4×	3.0k 1.5×	4.1k 2.3×	583 0.5×	297	15.4k
Patrick S. Parfrey	6.1k 1.2×	3.8k 1.4×	2.1k 1.1×	2.1k 1.2×	1.5k 1.2×	242	14.9k
Robert C. Atkins	7.6k 1.5×	4.3k 1.6×	2.2k 1.1×	2.0k 1.1×	782 0.6×	243	18.3k

Countries citing papers authored by David Goldsmith

Since Specialization

Citations

This map shows the geographic impact of David Goldsmith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Goldsmith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Goldsmith more than expected).

Fields of papers citing papers by David Goldsmith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Goldsmith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Goldsmith. The network helps show where David Goldsmith may publish in the future.

Co-authorship network of co-authors of David Goldsmith

This figure shows the co-authorship network connecting the top 25 collaborators of David Goldsmith. A scholar is included among the top collaborators of David Goldsmith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Goldsmith. David Goldsmith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jahangiri, Younes, et al.. (2025). Effectiveness of pre-operative chemical component separation with computed tomography-guided intramuscular injection of OnabotulinumtoxinA in outcomes of large complex incisional ventral abdominal hernia repair: a propensity score-weighted comparative analysis. Hernia. 29(1). 171–171.

Goldsmith, David, et al.. (2024). First clinical evaluation of the safety and efficacy of tarumase for the debridement of venous leg ulcers. International Wound Journal. 21(3). e14805–e14805. 1 indexed citations

Pouncey, Anna Louise, et al.. (2019). Examination of the Effect of Percutaneous Mechanical Thrombectomy on Acute Kidney Function, Following Intervention for Acute Iliofemoral Deep Venous Thrombosis. European Journal of Vascular and Endovascular Surgery. 58(6). e844–e845. 1 indexed citations

Ureña‐Torres, Pablo, Marc Vervloet, Sandro Mazzaferro, et al.. (2018). Novel insights into parathyroid hormone: report of The Parathyroid Day in Chronic Kidney Disease. Clinical Kidney Journal. 12(2). 269–280. 29 indexed citations

McIntyre, Christopher W. & David Goldsmith. (2015). Ischemic brain injury in hemodialysis patients: which is more dangerous, hypertension or intradialytic hypotension?. Kidney International. 87(6). 1109–1115. 77 indexed citations

McGregor, Reuben, et al.. (2014). Vitamin D in Renal Transplantation – from Biological Mechanisms to Clinical Benefits. American Journal of Transplantation. 14(6). 1259–1270. 41 indexed citations

Goldsmith, David, et al.. (2013). Thiopurine toxicity. British Journal of Hospital Medicine. 74(Sup10). C153–C156.

Jager, Kitty J., Bengt Lindholm, David Goldsmith, et al.. (2011). Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link?. Kidney International Supplements. 1(1). 21–23. 42 indexed citations

London, Gérard M., Adrian Covic, David Goldsmith, et al.. (2011). Arterial aging and arterial disease: interplay between central hemodynamics, cardiac work, and organ flow—implications for CKD and cardiovascular disease. Kidney International Supplements. 1(1). 10–12. 41 indexed citations

10.

Zoccali, Carmine, David Goldsmith, Rajiv Agarwal, et al.. (2011). The complexity of the cardio–renal link: taxonomy, syndromes, and diseases. Kidney International Supplements. 1(1). 2–5. 22 indexed citations

11.

Sadideen, Hazim, Paul Blaker, Patrick O’Donnell, John L. Taylor, & David Goldsmith. (2008). Tuberculosis complicating tertiary hyperparathyroidism in a patient with end-stage renal disease: a case report. Journal of Nephrology. 21(3). 438–441. 7 indexed citations

12.

Locatelli, Francesco & David Goldsmith. (2007). Biosimilars: uncharted territory. Journal of Nephrology. 20(3). 265–267. 1 indexed citations

13.

Kessler, M., David Goldsmith, & Huub Schellekens. (2006). Immunogenicity of biopharmaceuticals. Nephrology Dialysis Transplantation. 21(suppl_5). v9–v12. 151 indexed citations

14.

Covic, Adrian, et al.. (2006). Serial echocardiographic changes in patients on hemodialysis: an evaluation of guideline implementation. Journal of Nephrology. 19(6). 783–793. 23 indexed citations

15.

Buhăescu, Irina, Liviu Segall, David Goldsmith, & Adrian Covic. (2005). New immunosuppressive therapies in renal transplantation: Monoclonal antibodies. Journal of Nephrology. 18(5). 529–536. 20 indexed citations

16.

Afzali, Behdad, Anna L. Taylor, & David Goldsmith. (2005). What we CAN do about chronic allograft nephropathy: Role of immunosuppressive modulations. Kidney International. 68(6). 2429–2443. 19 indexed citations

17.

Gavrilovici, Cristina, et al.. (2003). What is the role of ambulatory BP monitoring in pediatric nephrology?. Journal of Nephrology. 17(5). 642–652. 7 indexed citations

18.

Covic, Adrian, Paul Gusbeth–Tatomir, & David Goldsmith. (2003). The challenge of cardiovascular risk factors in end-stage renal disease. Journal of Nephrology. 16(4). 476–486. 39 indexed citations

19.

Afzali, Behdad, P Lumb, Neil Dalton, et al.. (2003). Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients. Journal of Nephrology. 16(4). 540–545. 22 indexed citations

20.

Goldsmith, David, et al.. (2001). Rectus sheath haematoma. The Lancet. 358(9291). 1409–1409. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact